methazolamide has been researched along with Coats Disease in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JJ | 1 |
| Sohn, EH | 1 |
| Folk, JC | 1 |
| Mahajan, VB | 1 |
| Kay, CN | 1 |
| Boldt, HC | 1 |
| Russell, SR | 1 |
1 other study available for methazolamide and Coats Disease
| Article | Year |
|---|---|
Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Fluorescein | 2014 |